Abstract:Multi‐color (or multi‐marker) fluorescence in situ hybridization (mFISH) is a well‐established, valuable, complementary tool for prenatal and pathological (tumor) diagnosis. A variety of chromosomal abnormalities, such as partial or total chromosomal gains, losses, inversions, or translocations, which are considered to cause genetic syndromes, can relatively easily be detected on a cell‐by‐cell basis. Individual cells either in suspension (e.g., in the form of a cytological specimen derived from body fluids) or within a tissue (e.g., a solid tumor specimen or biopsy) can be quantitatively evaluated with respect to the chromosomal hybridization markers of interest (e.g., a gene or centromeric region) and with due consideration of cellular heterogeneity. FISH is helpful or even essential for the (sub‐)classification, stratification, and unambiguous diagnosis of a number of malignant diseases and contributes to treatment decision in many cases. Here, the diagnostic power and limitations of typical FISH and mFISH approaches (except chromosome painting and RNA hybridization) are discussed, with special emphasis on tumor and single‐cell diagnostics. Well‐established and novel FISH protocols, the latter addressed to accelerate and flexibilize the preparation and hybridization of formalin‐fixed and paraffin‐embedded tissues, are provided. Moreover, guidelines and molecular aspects important for data interpretation are discussed. Finally, sophisticated multiplexed approaches and those that analyze very rare single‐cell events, which are not yet implemented in diagnostic procedures, will be touched upon. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: (m)FISH applied to formaldehyde‐fixed paraffin‐embedded tissues Basic Protocol 2: (m)FISH applied to cytological specimens

Application of fluorescence in situ hybridization in the diagnosis of solid tumors

Progress in the application of FISH for the molecular characterization of lymphomas

Fluorescence in Situ Hybridization in Surgical Pathology: Principles and Applications

Fluorescence In-situ Hybridization (FISH) and Its Application in Oncology

Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors

Detection of chromosome number abnormalities in lung cancer by fluorescence in situ hybridization

Clinical Application of Multicolor Fluorescence in Situ Hybridization on Early Diagnosis of Lung Cancer

Complementary Tumor Diagnosis by Single Cell–Based Cytogenetics Using Multi‐marker Fluorescence In Situ Hybridization (mFISH)

Application of Fluorescence In Situ Hybridization (FISH)in Medical Microbiology

The clinical application of fluoresence in situ hybridization in diagnosis of urothelial bladder cancer

Applications of fluorescence in situ hybridization (FISH) in genome research

The Establishment and Clinical Application of Multicolor Fluorescence in Situ Hybridization

Detection of Chromosomal Aberration in Paraffin-Embedded Synovial Sarcoma Tissues by Fluorescence In-Situ Hybridization

Deep learning method for detecting fluorescence spots in cancer diagnostics via fluorescence in situ hybridization

Enhancing Specific Fluorescence In Situ Hybridization with Quantum Dots for Single-Molecule RNA Imaging in Formalin-Fixed Paraffin-Embedded Tumor Tissues

Applications of Hyperspectral Imaging in the Detection and Diagnosis of Solid Tumors

Application of Double Fluorescence in Situ Hybridization Technology in the Diagnosis of Bladder Urothelial Carcinoma

Advances in early detection methods for solid tumors

UroVysionTM Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives

Accurate Fluorescence Diagnosis of Cancer Based on Sequential Detection of Hydrogen Sulfide and pH

The Application of Nucleic Acid Probe–Based Fluorescent Sensing and Imaging in Cancer Diagnosis and Therapy